Skip to main content

Cerebrovascular Complications of Cancer

  • Chapter
  • First Online:
Cancer Neurology in Clinical Practice
  • 1831 Accesses

Abstract

A wide variety of cerebrovascular disorders can complicate the clinical course of cancer patients and, in rare instances, can be the presenting sign of cancer. Central nervous system (CNS) hemorrhage and ischemic events are typically symptomatic. Hemorrhage can occur into the parenchymal, subdural, epidural, or subarachnoid compartments and usually presents with symptoms typical for those sites. Cerebral infarction may cause focal signs, presenting as a transient ischemic attack (TIA) or infarction, or may cause encephalopathy when there are multiple and progressive small infarctions. The most common mechanisms of cerebrovascular disease in cancer patients are related to the presence of CNS tumor, either primary or metastatic, and coagulopathy. The coagulopathy in many instances is a direct effect of the neoplasm; in other cases it develops from cancer treatment. Cancer treatment can also result in blood vessel injury. Radiation therapy directed to the neck or brain can result in vessel stenosis, thrombosis and other vascular pathologies. Chemotherapy and molecularly-targeted agents can lead to vascular injury or thrombosis resulting in hemorrhage or infarction. Infection is a less common cause of stroke. It is important to identify cerebrovascular disease as the cause of neurologic symptoms in the cancer patient in order to determine appropriate evaluation and treatment. This is usually possible by a careful review of the cancer histology and sites of disease, types of antineoplastic therapy administered, and associated comorbidities. Laboratory studies of coagulation function and CNS imaging techniques are useful in identifying the precise etiology of the cerebrovascular disorder. Prompt diagnosis leads to appropriate therapy that, in certain patients, can improve the quality of life and survival as well as prevent additional vascular episodes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine. 1985;64:16–35.

    Article  CAS  PubMed  Google Scholar 

  2. Zoller B, Sundquist JJ, Sundquist K. Risk of haemorrhagic and ischemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012;48:1875–83.

    Article  PubMed  Google Scholar 

  3. Navi BB, Reichman JS, Berlin D, et al. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology. 2010;74:494–501.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Cestari DM, Weine DM, Panageas KS, et al. Stroke in patients with cancer: Incidence and etiology. Neurology. 2004;62:2025–30.

    Article  CAS  PubMed  Google Scholar 

  5. Noji C, Cohen K, Jordan LC. Hemorrhagic and ischemic stroke in children with cancer. Pediatr Neurol. 2013;49:1875–83.

    Google Scholar 

  6. Taccone FS, Jeangette SM, Blecic SA. First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis. 2008;17:169–74.

    Article  PubMed  Google Scholar 

  7. Kneihsl M, Enzinger C, Wunsch G, et al. Poor short-term outcome in patients with ischaemic stroke and active cancer. J Neurol. 2016;263:150–6.

    Article  CAS  PubMed  Google Scholar 

  8. Schrader B, Barth H, Lang EW. Spontaneous intracranial haematomas caused by neoplasms. Acta Neurochir (Wien). 2000;142:979–85.

    Article  CAS  Google Scholar 

  9. Abraham NA, Prayson RA. The role of histopathologic examination of intracranial blood clots removed for hemorrhage of unknown etiology: a clinical pathologic analysis of 31 cases. Ann Diagn Pathol. 2000;4:361–6.

    Article  Google Scholar 

  10. Yuguang L, Meng L, Shugan Z, et al. Intracranial tumoural haemorrhage—a report of 58 cases. J Clin Neurosci. 2002;9:637–9.

    Article  PubMed  Google Scholar 

  11. Jiang XB, Ke C, Zhang GH, et al. Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors. BMC Cancer. 2012;12:49.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Liwnicz BH, Wu SZ, Tew JM. The relationship between the capillary structure and hemorrhage in gliomas. J Neurosurg. 1987;66:536–41.

    Article  CAS  PubMed  Google Scholar 

  13. Bosnjak R, Derham C, Popović M, Ravnik J. Spontaneous intracranial meningioma bleeding: clinicopathological features and outcome. J Neurosurg. 2005;103:473–84.

    Article  PubMed  Google Scholar 

  14. Katz JM, Segal AZ. Incidence and etiology of cerebrovascular disease in patients with malignancy. Curr Atheroscler Rep. 2005;7:280–8.

    Article  PubMed  Google Scholar 

  15. Jung S, Moon K-S, Jung T-Y, et al. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage. J Neurooncol. 2006;76:257–63.

    Article  CAS  PubMed  Google Scholar 

  16. Atlas SW, Grossman RI, Gomori JM, et al. Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging. Radiology. 1987;164:71–7.

    Article  CAS  PubMed  Google Scholar 

  17. Kamel H, Navi BB, Hemphill C. A rule to identify patients who require magnetic resonance imaging after intracerebral hemorrhage. Neurocrit Care. 2013;1:59–63.

    Article  Google Scholar 

  18. Boellis A, diNapoli A, Romano A, Bozzao A. Pituitary apoplexy: an update on clinical and imaging features. Insights Imaging. 2014;5:753–62.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Singh TD, Valizadeh N, Meyer FB, Atkinson JL, Erickson D, Rabinstein AA. Management and outcomes of pituitary apoplexy. J Neurosurg. 2015;122:1450–7.

    Article  CAS  PubMed  Google Scholar 

  20. Reichman J, Singer S, Navi B, et al. Subdural hematoma in patients with cancer. Neurosurgery. 2012;71:74–9.

    Article  PubMed  Google Scholar 

  21. Laigle-Donadey F, Taillibert S, Mokhtari K, et al. Dural metastases. J Neurooncol. 2005;75:57–61.

    Article  PubMed  Google Scholar 

  22. Hata A, Fujita S, Katakami N, Sakai C, Imai Y. Bilateral subdural hematoma associated with central nervous system metastasis from lung cancer. J Thorac Oncol. 2011;6:207–8.

    Article  PubMed  Google Scholar 

  23. Raizer JJ, DeAngelis LM. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology. 2000;54:1222–6.

    Article  CAS  PubMed  Google Scholar 

  24. Oda N, Sakugawa M, Bessho A, et al. Cerebral venous sinus thrombosis concomitant with leptomeningeal carcinomatosis, in a patient with epidermal growth factor receptor-mutated lung cancer. Oncol Lett. 2014;8:2489–92.

    PubMed  PubMed Central  Google Scholar 

  25. Zheng J, Zhang J. Neoplastic cerebral aneurysm from metastatic tumor: a systematic review of clinical and treatment characteristics. Clin Neurol Neurosurg. 2015;128:107–11.

    Article  PubMed  Google Scholar 

  26. Nomura R, Yoshida D, Kim K, Kobayashi S, Teramoto A. Intracerebral hemorrhage caused by a neoplastic aneurysm from pleomorphic lung carcinoma. Neurol Med Chir (Tokyo). 2009;49:33–6.

    Article  Google Scholar 

  27. Gutmann DH, Cantor CR, Piacente GJ, McCluskey LF. Cerebral vasculopathy and infarction in a woman with carcinomatous meningitis. J Neurooncol. 1990;9:183–5.

    Article  CAS  PubMed  Google Scholar 

  28. Herman C, Kupsky WJ, Rogers L, Duman R, Moore P. Leptomeningeal dissemination of malignant glioma simulating cerebral vasculitis. Stroke. 1995;26:2366–70.

    Article  CAS  PubMed  Google Scholar 

  29. Artoni A, Bucciarelli P, Martinelli I. Cerebral thrombosis and myeloproliferative neoplasms. Curr Neurol Neurosci Rep. 2014;14:496.

    Article  PubMed  CAS  Google Scholar 

  30. Enblom A, Lindskog E, Hasselbalch H, et al. High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms. Eur J Intern Med. 2015;26:344–7.

    Article  PubMed  Google Scholar 

  31. Koenig MK, Sitton CW, Wang M, Slopis JM. Central nervous system complications of blastic hyperleukocytosis in childhood acute lymphoblastic leukemia: diagnostic and prognostic implications. J Child Neurol. 2008;23:1347–52.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Pham HP, Schwartz J. How we approach a patient with symptoms of leukostasis requiring emergent leukocytapheresis. Transfusion. 2015;55:2306–11.

    Article  CAS  PubMed  Google Scholar 

  33. Ferro A, Jabbour SK, Taunk NK, et al. Cranial irradiation in adults diagnosed with acute myelogenous leukemia presenting with hyperleukocytosis and neurologic dysfunction. Leuk Lymphoma. 2014;55:105–9.

    Article  PubMed  Google Scholar 

  34. Fonkem E, Lok E, Robison D, Gautam S, Wong ET. The natural history of intravascular lymphomatosis. Cancer Med. 2014;3:1010–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Baehring JM, Henchcliffe C, Ledezma CH, Fulbright R, Hochberg FH. Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system. J Neurol Neurosurg Psychiatry. 2005;76:540–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Dias RR, Fernandes F, Ramires FJ, Mady C, Albuquerque CP, Jatene FB. Mortality and embolic potential of cardiac tumors. Arq Bras Cardiol. 2014;103:13–8.

    PubMed  PubMed Central  Google Scholar 

  37. Abraham KP, Reddy V, Gattuso P. Neoplasms metastatic to the heart: review of 3314 consecutive autopsies. Am J Cardiovasc Pathol. 1990;3:195–8.

    CAS  PubMed  Google Scholar 

  38. Navi BB, Kawaguchi K, Hriljac I, et al. Multifocal stroke from tumor emboli. Arch Neurol. 2009;66:1174–5.

    Article  PubMed  Google Scholar 

  39. Spaulding R, Koumoundouros T, Parker JC. Metastatic undifferentiated pleomorphic sarcoma causing intraoperative stroke. Ann Clin Lab Sci. 2013;43:172–5.

    PubMed  Google Scholar 

  40. Schwarzbach CJ, Schaefer A, Ebert A, et al. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke. 2012;43:3029–34.

    Article  PubMed  Google Scholar 

  41. Yusuf SW, Ali SS, Swafford J, et al. Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994–2004. Medicine (Baltimore). 2006;85:86–94.

    Article  Google Scholar 

  42. Merkler AE, Navi BB, Singer S, et al. Diagnostic yield of echocardiography in cancer patients with ischemic stroke. J Neurooncol. 2015;123:115–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Singhal AB, Topcuoglu MA, Buonanno FS. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study. Stroke. 2002;33:1267–73.

    Article  PubMed  Google Scholar 

  44. Lafitte F, Boukobza M, Guichard JP, et al. MRI and MRA for diagnosis and follow-up of cerebral venous thrombosis. Clin Radiol. 1997;52:672–9.

    Article  CAS  PubMed  Google Scholar 

  45. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597–600.

    Article  CAS  PubMed  Google Scholar 

  46. De Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;304:484–8.

    Article  Google Scholar 

  47. Santoro N, Giordano P, Del Vecchio GC, et al. Ischemic stroke in children treated for acute lymphoblastic leukemia. A retrospective study. J Pediatr Hematol Oncol. 2005;27:153–7.

    Article  PubMed  Google Scholar 

  48. Ranta S, Tuckuviene R, Makipernaa A, et al. Cerebral venous thromboses in children with acute lymphoblastic leukaemia—a multicenter study from the Nordic Society of Paediatric Haematology and Oncology. Br J Haematol. 2015;4:547–52.

    Article  Google Scholar 

  49. Choudhri O, Feroze A, Marks MP, Do HM. Endovascular management of cerebral venous sinus thrombosis. Neurosurg Focus. 2014;37(Suppl 1):1.

    Google Scholar 

  50. Viegas LD, Stolz E, Canhão P, Ferro JM. Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review. Cerebrovasc Dis. 2014;37:43–50.

    Article  CAS  PubMed  Google Scholar 

  51. Gonzalez Quintela A, Candela MJ, Vidal C, et al. Nonbacterial thrombotic endocarditis in cancer patients. Acta Cardiol. 1991;46:1–9.

    CAS  PubMed  Google Scholar 

  52. Rogers LR, Cho E, Kempin S, et al. Cerebral infarction from nonbacterial thrombotic endocarditis. Am J Med. 1987;83:746–58.

    Article  CAS  PubMed  Google Scholar 

  53. Min KW, Gyorkey F, Sato C. Mucin-producing adenocarcinomas and nonbacterial thrombotic endocarditis: pathogenic role of tumor mucin. Cancer. 1980;45:2374–82.

    Article  CAS  PubMed  Google Scholar 

  54. Biller J, Challa VR, Toole JF, et al. Nonbacterial thrombotic endocarditis: a neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol. 1982;39:95–8.

    Article  CAS  PubMed  Google Scholar 

  55. Amico L, Caplan LR, Thomas C. Cerebrovascular complications of mucinous cancers. Neurology. 1989;39:522–6.

    Article  CAS  PubMed  Google Scholar 

  56. Bernardo MC, Menke J, Scheithauer B, et al. Intravascular mucinosis: a rare cause of cerebral infarction. Acta Neuropathol. 2011;121:785–8.

    Article  PubMed  Google Scholar 

  57. Towfighi J, Simmonds MA, Davidson EA. Mucin and fat emboli in mucinous carcinomas. Cause of hemorrhagic cerebral infarcts. Arch Pathol Lab Med. 1983;107:646–9.

    CAS  PubMed  Google Scholar 

  58. Arkel YS. Thrombosis and cancer. Semin Oncol. 2000;27:362–74.

    CAS  PubMed  Google Scholar 

  59. Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341:586–92.

    Article  CAS  PubMed  Google Scholar 

  60. Mantha S, Tallman M, Soff GA. What’s new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia? Curr Opin Hematol. 2016;23(2):121–6.

    Article  CAS  PubMed  Google Scholar 

  61. Sallah S, Wan JY, Nguyen NP, et al. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost. 2011;86:828–33.

    Google Scholar 

  62. Sakuragawa N, Hasegawa H, Maki M, et al. Clinical evaluation of low-molecular-weight–heparin (FR-860) on disseminated intravascular coagulation (DIC): a multicenter co-operative, double-blind trial in comparison with heparin. Thromb Res. 1993;72:475–500.

    Article  CAS  PubMed  Google Scholar 

  63. Avvisati G, ten Cate JW, Buller HR, et al. Tranexamic acid for control of hemorrhage in acute promyelocytic leukaemia. Lancet. 1989;2:122–4.

    Article  CAS  PubMed  Google Scholar 

  64. Lechner K, Obermeier HL. Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases. Medicine (Baltimore). 2012;91:195–205.

    Article  Google Scholar 

  65. Kaden BR, Rosse WF, Hauch TW. Immune thrombocytopenia in lymphoproliferative diseases. Blood. 1979;53:545–51.

    CAS  PubMed  Google Scholar 

  66. Gordon LI, Kwaan HC. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Semin Thromb Hemost. 1999;25:217–21.

    Article  CAS  PubMed  Google Scholar 

  67. Omura M, Aida N, Sakido K, et al. Large intracranial vessel occlusive vasculopathy after radiation therapy in children: clinical features and usefulness of magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 1997;38:241–9.

    Article  CAS  PubMed  Google Scholar 

  68. Fouladi M, Langston J, Mulhern R, et al. Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Oncol. 2000;18:824–31.

    Article  CAS  PubMed  Google Scholar 

  69. Bowers DC, Liu Y, Leisenring W, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:5277–82.

    Article  PubMed  Google Scholar 

  70. Fullerton HJ, Stratton K, Mueller S, et al. Recurrent stroke in childhood cancer survivors. Neurology. 2015;85:1–9.

    Article  Google Scholar 

  71. Bowers DC, Mulne AF, Reisch JS, et al. Nonperioperative strokes in children with central nervous system tumors. Cancer. 2002;94:1094–101.

    Article  PubMed  Google Scholar 

  72. Campen CJ, Kranick SM, Kasner SE, et al. Cranial irradiation increases risk of stroke in pediatric brain tumor survivors. Stroke. 2012;43:3035–40.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Aizer AA, Du R, Wen PY, Arvold ND. Radiotherapy and death from cerebrovascular disease in patients with primary brain tumors. J Neurooncol. 2015;124:291–7.

    Article  CAS  PubMed  Google Scholar 

  74. Van Varsseveld NC, van Bunderen CC, Ubachs DH, et al. Cerebrovascular events, secondary intracranial tumors, and mortality after radiotherapy for nonfunctioning pituitary adenomas: a subanalysis from the Dutch national registry of growth hormone treatment in adults. J Clin Endocrinol Metabl. 2015;100:1104–12.

    Article  CAS  Google Scholar 

  75. Nanney AD, El Tecle NE, El Ahmadieh TY, et al. Intracranial aneurysms in previously irradiated fields: literature review and case report. World Neurosurg. 2014;81:511–9.

    Article  PubMed  Google Scholar 

  76. Kellner CP, McDowell MM, Connolly ES Jr, Sisti MB, Lavine SD. Late onset aneurysm development following radiosurgical obliteration of a cerebellopontine angle meningioma. BMJ Case Rep. 2014; 14. pii: bcr2014011206.

    Google Scholar 

  77. Matsumoto H, Minami H, Yamaura I, Oshida Y. Radiation-induced cerebal aneurysm treated with endovascular coil embolization. INR. 2014;20:448–53.

    Google Scholar 

  78. Li L, Mugikara AS, Kumabe T, et al. A comparative study of the extent of cerebral microvascular injury following whole-brain irradiation versus reduced-field irradiation in long-term survivors of intracranial germ cell tumors. Radiother Oncol. 2015;117:302–7.

    Article  PubMed  Google Scholar 

  79. Koike S, Aida N, Hata M, Fujita K, Ozawa Y, Inoue T. Asymptomatic radiation-induced telangiectasia in children after cranial irradiation: frequency, latency, and dose relation. Radiology. 2004;230:93–9.

    Article  PubMed  Google Scholar 

  80. Singla A, Brace O’Neill JE, Smith E, Scott RM. Cavernous malformations of the brain after treatment for acute lymphocytic leukemia: presentation and long-term follow-up. J Neurosurg Pediatr. 2013;11:127–32.

    Article  PubMed  Google Scholar 

  81. Nimjee SM, Powers CJ, Bulsara KR. Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy. Neurosurg Focus. 2006;21:e4.

    Article  PubMed  Google Scholar 

  82. Di Giannatale A, Morana G, Rossi A, et al. Naural history of cavernous malformations in children with brain tumors treated with radiotherapy and chemotherapy. J Neurooncol. 2014;117:311–20.

    Article  PubMed  CAS  Google Scholar 

  83. Yoshino M, Morita A, Shibahara J, Kirino T. Radiation-induced spinal cord cavernous malformation. Case report. J Neurosurg. 2005;102(Suppl 1):101–4.

    PubMed  Google Scholar 

  84. Koike T, Yanagimachi N, Ishiguro H, et al. High incidence of radiation-induced cavernous hemangioma in long-term survivors who underwent hematopoietic stem cell transplantation with radiation therapy during childhood or adolescence. Biol Blood Marrow Transplant. 2012;18:1090–8.

    Article  PubMed  Google Scholar 

  85. Desai SS, Paulino AC, Mai WY, Teh BS. Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys. 2006;65:1222–7.

    Article  PubMed  Google Scholar 

  86. Dorresteijn LD, Kappelle AC, Boogerd W, et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol. 2002;20:282–8.

    Article  PubMed  Google Scholar 

  87. Dorth JA, Patel PR, Broadwater G, Brizel DM. Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy. Head Neck. 2014;36:215–9.

    Article  PubMed  Google Scholar 

  88. Gujral DM, Shah BN, Chahal NS, et al. Do traditional risk stratification models for cerebrovascular events apply in irradiated head and neck cancer patients? QJM. 2016;109(6):383–9.

    Article  CAS  PubMed  Google Scholar 

  89. Bashar K, Healy D, Clarke-Moloney M, et al. Effects of neck radiation therapy on extra-cranial carotid arteries atherosclerosis disease prevalence: systematic review and a meta-analysis. PLoS ONE. 2014;9:e110389.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  90. Bowers DC, McNeil DE, Liu Y, et al. Stroke as a late treatment effect of Hodgkin’s disease: a report from the childhood cancer survivor study. J Clin Oncol. 2005;23:6508–15.

    Article  PubMed  Google Scholar 

  91. Black DF, Morris JM, Lindell EP, et al. Stroke-like migraine attacks after radiation therapy (SMART) syndrome is not always completely reversible. AJNR. 2013;34:2298–303.

    Article  CAS  PubMed  Google Scholar 

  92. Sano N, Satow T, Maruyama D, et al. Carotid endarterectomy carries less risk than stenting in patients with radiation-induced carotid stenosis. J Vasc Surg. 2015;62:370–7.

    Article  PubMed  Google Scholar 

  93. Cam A, Shishehbor MH, Bajaj NS, et al. Outcomes of carotid stenting in patients with previous neck radiation. Catheter Cardiovasc Interv. 2013;82:689–95.

    Article  PubMed  Google Scholar 

  94. Ravin RA, Gottlieb A, Pasternac K, et al. Carotid artery stenting may be performed safely in patients with radiation therapy-associated carotid stenosis without increased restenosis or target lesion revascularization. JVS. 2015;62:624–30.

    Google Scholar 

  95. Brinjikji W, Cloft HJ. Outcomes of endovascular occlusion and stenting in the treatment of carotid blowout. Interv Neuroradiol. 2015;21:543–7.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Brown DV, Faber LP, Tuman KJ. Perioperative stroke caused by arterial tumor embolism. Anesth Analg. 2004;98:806–9.

    PubMed  Google Scholar 

  97. Cho Y, Hida Y, Kaga K, Kato H, Iizuka M, Kondo S. Brain metastases secondary to tumor emboli from primary lung cancer during lobectomy. Ann Thorac Surg. 2008;86:312–3.

    Article  PubMed  Google Scholar 

  98. MacNeil SD, Liu K, Garg AX, Tam S, et al. A population-based study of 30-day incidence of ischemic stroke following surgical neck dissection. Medicine (Baltimore). 2015;94:e1106.

    Article  Google Scholar 

  99. Garza-Ramos RDl, Kerezoudis P, Tarmago RJ, et al. Surgical complications following malignant brain tumor surgery: an analysis of 2002–2011 data. Clin Neurol Neurosurg. 2015;140:6–10.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Gempt J, Gerhardt J, Toth V, et al. Postoperative ischemic changes following brain metastasis resection as measured by diffusion-weighted magnetic resonance imaging. J Neurosurg. 2013;119:1395–400.

    Article  PubMed  Google Scholar 

  101. Jakola AS, Berntsen EM, Christensen P, et al. Surgically acquired deficits and diffusion weighted MRI changes after glioma resection—a matched case-control study with blinded neuroradiological assessment. J Neurosurg. 2013;119:829–36.

    Article  Google Scholar 

  102. Smith JS, Cha S, Mayo MC, et al. Serial diffusion–weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg. 2005;103:428–38.

    Article  PubMed  Google Scholar 

  103. Gempt J, Krieg SM, Hüttinger S, et al. Postoperative ischemic changes after glioma resection identified by diffusion-weighted magnetic resonance imaging and their association with intraoperative motor evoked potentials. J Neurosurg. 2013;119:829–36.

    Article  PubMed  Google Scholar 

  104. Friedman JA, Piepgras DG, Duke DA, et al. Remote cerebellar hemorrhage after supratentorial surgery. Neurosurgery. 2001;49:1327–40.

    Article  CAS  PubMed  Google Scholar 

  105. Keiper GL, Sherman JD, Tomsick TA, et al. Dural sinus thrombosis and pseudotumor cerebri: unexpected complications of suboccitpital craniotomy and translabyrinthine craniectomy. J Neurosurg. 1999;91:192–7.

    Article  PubMed  Google Scholar 

  106. Quarante LH, Mena-Bernal JH, Martin BP, et al. Posterior reversible encephalopathy syndrome (PRES): a rare condition after resection of posterior fossa tumors: two new cases and review of the literature. Childs Nerv Syst. 2016;32(5):857–63.

    Article  Google Scholar 

  107. Burkhardt JK, Riina HA, Shin BJ, Moliterno JA, Hofstetter CP, Boockvar JA. Intra-arterial chemotherapy for malignant gliomas: a critical analysis. Interv Neuroradiol. 2011;17:286–95.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Kallmes DF, Evans AJ, Kaptain GJ, et al. Hemorrhagic complications in embolization of a meningioma: case report and review of the literature. Neuroradiology. 1997;39:877–80.

    Article  CAS  PubMed  Google Scholar 

  109. Shah A, Choudhari O, Jung H, Li G. Preoperative endovascular embolization of meningiomas: update on therapeutic options. Neurosurg Focus. 2015;38:e7.

    Article  PubMed  Google Scholar 

  110. Lee AY, Levine MN. The thrombophilic state induced by therapeutic agents in the cancer patient. Semin Thromb Hemost. 1999;25:137–45.

    Article  CAS  PubMed  Google Scholar 

  111. Bushman JE, Palmierir D, Whinna HC, et al. Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia. Leuk Res. 2000;24:559–65.

    Article  CAS  PubMed  Google Scholar 

  112. Gugliotta L, Mazzucconi MG, Leone G, et al. Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving l–aspariginase during induction therapy: a retrospective study. Eur J Haematol. 1992;49:63–6.

    Article  CAS  PubMed  Google Scholar 

  113. Koppelmans V, Vernooij MW, Boogerd W, et al. Prevalence of cerebral small-vessel disease in long-term breast cancer survivors exposed to both adjuvant radiotherapy and ehemotherapy. J Clin Oncol. 2015;33:588–93.

    Article  PubMed  Google Scholar 

  114. Patel SB, Gojo I, Tidwell ML, Sausvile EA, Baer MR. Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy. Leuk Lymphoma. 2011;52:1011–4.

    Article  CAS  Google Scholar 

  115. Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29:1036–42.

    Article  CAS  PubMed  Google Scholar 

  116. Singer S, Grommes C, Reiner AS, Rosenblum MK, DeAngelis LM. Posterior reversible encephalopathy syndrome in patients with cancer. Oncologist. 2015;20:806–11.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Hamo CE, Bloom MW. Getting to the heart of the matter: an overview of cardiac toxicity related to cancer therapy. Clin Med Insights Cardiol. 2015;9(Suppl 2):47–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  118. Bloom MW, Hamo CE, Cardinale D, et al. Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk Factors, and imaging. Circ Heart Fail. 2016;9:e002661.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Dietrich U, Hettmann M, Maschke M, et al. Cerebral aspergillosis: comparison of radiological and neuropathologic findings in patients with bone marrow transplantation. Eur Radiol. 2001;11:1242–9.

    Article  CAS  PubMed  Google Scholar 

  120. Gabelmann A, Klein S, Kern W, et al. Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients. Eur J Neurol. 2007;14:548–55.

    Article  CAS  PubMed  Google Scholar 

  121. Starkey J, Moritani T, Kirby P. MRI of CNS fungal infections: review of aspergillosis to histoplasmosis and everything in between. Clin Neuroradiol. 2014;24:217–30.

    Article  CAS  PubMed  Google Scholar 

  122. Jo JT, Schiff D, Perry JR. Thrombosis in brain tumors. Semin Thromb Hemost. 2014;40:325–31.

    Article  CAS  PubMed  Google Scholar 

  123. Norden AD, Bartolomeo J, Tanaka S, et al. Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients. J Neurooncol. 2012;106:121–5.

    Article  CAS  PubMed  Google Scholar 

  124. Coplin WM, Cochran MS, Levine SR, et al. Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain. 2001;124:1043–51.

    Article  CAS  PubMed  Google Scholar 

  125. Graus F, Saiz A, Sierra J, et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology. 1996;46:1004–9.

    Article  CAS  PubMed  Google Scholar 

  126. Colosimo M, McCarthy N, Jayasinghe R, et al. Diagnosis and management of subdural haematoma complicating bone marrow transplantation. Bone Marrow Transplant. 2000;25:549–52.

    Article  CAS  PubMed  Google Scholar 

  127. Bleggi-Torres LF, Werner B, Gasparetto EL, et al. Intracranial hemorrhage following bone marrow transplantation: an autopsy study of 58 patients. Bone Marrow Transplant. 2002;29:29–32.

    Article  CAS  PubMed  Google Scholar 

  128. Paquette RL, Tran L, Landaw EM. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant. 1998;22:351–7.

    Article  CAS  PubMed  Google Scholar 

  129. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant. 1994;14:495–504.

    CAS  PubMed  Google Scholar 

  130. Le Guennec L, Roos-Weil D, Mokhtari K, et al. Granulomatous angiitis of the CNS revealing a Hodgkin lymphoma. Neurology. 2013;80:323–4.

    Article  PubMed  Google Scholar 

  131. Kalafut M, Vinuela F, Saver JL, et al. Multiple cerebral pseudoaneurysms and hemorrhages: the expanding spectrum of metastatic cerebral choriocarcinoma. J Neuroimaging. 1998;8:44–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lisa R. Rogers .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Rogers, L.R. (2018). Cerebrovascular Complications of Cancer. In: Schiff, D., Arrillaga, I., Wen, P. (eds) Cancer Neurology in Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-57901-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-57901-6_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-57899-6

  • Online ISBN: 978-3-319-57901-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics